Advertisement
Liquidia Corporation

Liquidia Corporation (LQDA) Stock Overview

Explore Liquidia Corporation’s financial performance, market position, analyst ratings, and future outlook.

LQDANASDAQ
HealthcareBiotechnology
$75.54
$1.50(2.03%)
U.S. Market opens in 7h 43m
Advertisement

Liquidia Corporation (LQDA)

Meyka AI Score

Z

Key Financials

Market Cap6.7B
P/E Ratio318.29
EPS (TTM)$0.14
ROE0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$80.32
3 Months$65.07
1 Year Target$64.27

LQDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Liquidia Corporation (LQDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 72.05, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $64.27.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 318.29 and a market capitalization of 6.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.03%
5-Day Change
3.52%
1-Month Change
23.88%
3-Month Change
114.60%
6-Month Change
111.06%
Year-to-Date (YTD) Change
119.02%
1-Year Change
448.19%
3-Year Change
740.27%
5-Year Change
2550.53%
All-Time (Max) Change
580.54%

Contact Information

919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

1,700 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions